Cited by 512DNA Repair MechanismsBRCA gene mutations in cancerPARP inhibition in cancer therapy

Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress

Open access
Tibbetts, Randal S., Cortez, David, Brumbaugh, Kathryn M., Scully, Ralph, Livingston, David, Elledge, Stephen J., Abraham, Robert T.·2000·Genes & Development

Abstract

The BRCA1 gene encodes a tumor suppressor that is mutated in 50% of familial breast cancers. The BRCA1 protein has been implicated in the DNA damage response, as DNA damage induces the phosphorylation of BRCA1 and causes its recruitment into nuclear foci that contain DNA repair proteins. The ataxia-telangiectasia-mutated (ATM) gene product controls overall BRCA1 phosphorylation in response to γ-irradiation (IR). In this study, we show that BRCA1 phosphorylation is only partially ATM dependent in response to IR and ATM independent in response to treatment with UV light, or the DNA replication inhibitors hydroxyurea (HU) and aphidicolin (APH). We provide evidence that the kinase responsible for this phosphorylation is the ATM-related kinase, ATR. ATR phosphorylates BRCA1 on six Ser/Thr residues, including Ser 1423, in vitro. Increased expression of ATR enhanced the phosphorylation of BRCA1 on Ser 1423 following cellular exposure to HU or UV light, whereas doxycycline-induced expression of a kinase-inactive ATR mutant protein inhibited HU- or UV light-induced Ser 1423 phosphorylation in GM847 fibroblasts, and partially suppressed the phosphorylation of this site in response to IR. Thus, ATR, like ATM, controls BRCA1 phosphorylation in vivo. Although ATR isolated from DNA-damaged cells does not show enhanced kinase activity in vitro, we found that ATR responds to DNA damage and replication blocks by forming distinct nuclear foci at the sites of stalled replication forks. Furthermore, ATR nuclear foci overlap with the nuclear foci formed by BRCA1. The dramatic relocalization of ATR in response to DNA damage points to a possible mechanism for its ability to enhance the phosphorylation of substrates in response to DNA damage. Together, these results demonstrate that ATR and BRCA1 are components of the same genotoxic stress-responsive pathway, and that ATR directly phosphorylates BRCA1 in response to damaged DNA or stalled DNA replication.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.851000

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tibbetts, R. S., Cortez, D., Brumbaugh, K. M., Scully, R., Livingston, D., Elledge, S. J., & Abraham, R. T.
Affiliations
Howard Hughes Medical Institute (US)
Venue
Genes & Development
Published
2000-12-01
Volume
14
Issue
23
Pages
2989-3002
ISSN
  • 0890-9369 (ISSN-L)
  • 1549-5477
OpenAlex
W2005284058
Cited by
512
References
66
Citations by year
2026: 3 · 2025: 7 · 2024: 4 · 2023: 8 · 2022: 12 · 2021: 13 · 2020: 7 · 2019: 8 · 2018: 11 · 2017: 9 · 2016: 7 · 2015: 16 · 2014: 13 · 2013: 18 · 2012: 12
Type
posted content
Language
en
Open access
Locations
  • Genes & Development (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense
  • Howard Hughes Medical Institute
  • Jane Coffin Childs Memorial Fund for Medical Research
  • Wellcome Trust
  • National Institutes of Health
  • Johnson and Johnson
  • National Cancer Institute (CA76193, U01CA052995, CA-52995, R01CA076193, F32CA083319, U19CA052995)
  • National Institute of General Medical Sciences (GM-44664, R37GM044664, R01GM044664)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords
BRCA1, ATR kinase, ATM, BRCA1 phosphorylation, DNA damage response, genotoxic stress, replication stress, stalled replication forks, nuclear foci, ultraviolet radiation, hydroxyurea, aphidicolin, gamma irradiation, tumor suppressor
MeSH terms
Animals, Catalysis, Cell Line, Transformed, Cell Nucleus, DNA Damage, DNA Repair, Humans, Phosphorylation, Rabbits, Serine, Signal Transduction, Gene Expression, Protein Serine-Threonine Kinases, Cell Cycle Proteins, BRCA1 Protein, K562 Cells, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review